Calcium dysregulation in amyotrophic lateral sclerosis.

PubWeight™: 1.43‹?› | Rank: Top 5%

🔗 View Article (PMID 20116097)

Published in Cell Calcium on January 29, 2010

Authors

Julian Grosskreutz1, Ludo Van Den Bosch, Bernhard U Keller

Author Affiliations

1: Dept. of Neurology, Friedrich-Schiller University Hospital Jena, Erlanger Allee 101, 07747 Jena, Germany. julian.grosskreutz@med.uni-jena.de

Articles citing this

Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol (2011) 2.73

A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell Stem Cell (2013) 2.14

Insights from cerebellar transcriptomic analysis into the pathogenesis of ataxia. JAMA Neurol (2014) 1.51

Progressive degeneration of dopaminergic neurons through TRP channel-induced cell death. J Neurosci (2014) 1.43

Endoplasmic reticulum Ca(2+) handling in excitable cells in health and disease. Pharmacol Rev (2011) 1.38

The Mitochondrial Permeability Transition Pore: Channel Formation by F-ATP Synthase, Integration in Signal Transduction, and Role in Pathophysiology. Physiol Rev (2015) 1.31

SOD1 and mitochondria in ALS: a dangerous liaison. J Bioenerg Biomembr (2011) 1.24

Mitochondrial dysfunction in familial amyotrophic lateral sclerosis. J Bioenerg Biomembr (2011) 1.23

Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration. Int Rev Cell Mol Biol (2013) 1.23

Probing mechanisms that underlie human neurodegenerative diseases in Drosophila. Annu Rev Genet (2012) 1.21

VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. Hum Mol Genet (2011) 1.19

Mitochondria, calcium-dependent neuronal death and neurodegenerative disease. Pflugers Arch (2012) 1.16

The complex molecular biology of amyotrophic lateral sclerosis (ALS). Prog Mol Biol Transl Sci (2012) 1.05

Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria. Hum Mol Genet (2012) 1.03

The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis. Front Cell Neurosci (2014) 1.02

Microglia centered pathogenesis in ALS: insights in cell interconnectivity. Front Cell Neurosci (2014) 1.00

Sigma-1R agonist improves motor function and motoneuron survival in ALS mice. Neurotherapeutics (2012) 0.98

Mitochondrial Ca(2+) and neurodegeneration. Cell Calcium (2012) 0.97

A dominant mutation in a neuronal acetylcholine receptor subunit leads to motor neuron degeneration in Caenorhabditis elegans. J Neurosci (2010) 0.94

Selective mitochondrial Ca2+ uptake deficit in disease endstage vulnerable motoneurons of the SOD1G93A mouse model of amyotrophic lateral sclerosis. J Physiol (2013) 0.93

Early pathogenesis in the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J Cell Biochem (2012) 0.92

Calcium channel blockers and dementia. Br J Pharmacol (2013) 0.91

State of the field: An informatics-based systematic review of the SOD1-G93A amyotrophic lateral sclerosis transgenic mouse model. Amyotroph Lateral Scler Frontotemporal Degener (2015) 0.89

Exposure of neurons to excitotoxic levels of glutamate induces cleavage of the RNA editing enzyme, adenosine deaminase acting on RNA 2, and loss of GLUR2 editing. Neuroscience (2011) 0.86

ER stress and unfolded protein response in amyotrophic lateral sclerosis-a controversial role of protein disulphide isomerase. Front Cell Neurosci (2014) 0.86

Mitochondria in motor nerve terminals: function in health and in mutant superoxide dismutase 1 mouse models of familial ALS. J Bioenerg Biomembr (2011) 0.85

ER Stress-Mediated Signaling: Action Potential and Ca(2+) as Key Players. Int J Mol Sci (2016) 0.84

Calcium dysregulation links ALS defective proteins and motor neuron selective vulnerability. Front Cell Neurosci (2015) 0.84

C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Stem Cells (2016) 0.83

Dysfunctional mitochondrial Ca(2+) handling in mutant SOD1 mouse models of fALS: integration of findings from motor neuron somata and motor terminals. Front Cell Neurosci (2014) 0.80

Regulation of nuclear TDP-43 by NR2A-containing NMDA receptors and PTEN. J Cell Sci (2012) 0.80

Ca2+ entry pathways in mouse spinal motor neurons in culture following in vitro exposure to methylmercury. Neurotoxicology (2011) 0.79

Mitochondria-associated membrane collapse is a common pathomechanism in SIGMAR1- and SOD1-linked ALS. EMBO Mol Med (2016) 0.79

Reactive oxygen species trigger motoneuron death in non-cell-autonomous models of ALS through activation of c-Abl signaling. Front Cell Neurosci (2015) 0.79

Exposure to an environmental neurotoxicant hastens the onset of amyotrophic lateral sclerosis-like phenotype in human Cu2+/Zn2+ superoxide dismutase 1 G93A mice: glutamate-mediated excitotoxicity. J Pharmacol Exp Ther (2011) 0.79

Intraspinal stem cell transplantation for amyotrophic lateral sclerosis. Ann Neurol (2016) 0.79

Calcium ions promote superoxide dismutase 1 (SOD1) aggregation into non-fibrillar amyloid: a link to toxic effects of calcium overload in amyotrophic lateral sclerosis (ALS)? J Biol Chem (2013) 0.79

The Dual Function of Reactive Oxygen/Nitrogen Species in Bioenergetics and Cell Death: The Role of ATP Synthase. Oxid Med Cell Longev (2016) 0.78

Delayed administration of VEGF rescues spinal motor neurons from death with a short effective time frame in excitotoxic experimental models in vivo. ASN Neuro (2012) 0.78

Homeostatic dysregulation in membrane properties of masticatory motoneurons compared with oculomotor neurons in a mouse model for amyotrophic lateral sclerosis. J Neurosci (2015) 0.78

Neurobiology of axonal transport defects in motor neuron diseases: Opportunities for translational research? Neurobiol Dis (2017) 0.77

Role of energy metabolic deficits and oxidative stress in excitotoxic spinal motor neuron degeneration in vivo. ASN Neuro (2014) 0.77

Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G⁹³A ALS mice: overlapping effects or limited therapeutic opportunity? Orphanet J Rare Dis (2014) 0.77

ALS Patient Stem Cells for Unveiling Disease Signatures of Motoneuron Susceptibility: Perspectives on the Deadly Mitochondria, ER Stress and Calcium Triad. Front Cell Neurosci (2015) 0.77

Benzothiazepine CGP37157 and its isosteric 2'-methyl analogue provide neuroprotection and block cell calcium entry. ACS Chem Neurosci (2012) 0.76

PGC-1α Silencing Compounds the Perturbation of Mitochondrial Function Caused by Mutant SOD1 in Skeletal Muscle of ALS Mouse Model. Front Aging Neurosci (2015) 0.76

Voltage-gated calcium channels are abnormal in cultured spinal motoneurons in the G93A-SOD1 transgenic mouse model of ALS. Neurobiol Dis (2016) 0.76

Novel molecular biomarkers at the blood-brain barrier in ALS. Biomed Res Int (2014) 0.76

Promise and Pitfalls of Mitochondrial Replacement for Prevention and Cure of Heritable Neurodegenerative Diseases Caused by Deleterious Mutations in Mitochondrial DNA. Front Cell Neurosci (2016) 0.76

Stronger is not always better: could a bodybuilding dietary supplement lead to ALS? Exp Neurol (2010) 0.76

Elevated mRNA-levels of distinct mitochondrial and plasma membrane Ca(2+) transporters in individual hypoglossal motor neurons of endstage SOD1 transgenic mice. Front Cell Neurosci (2014) 0.76

Mitochondria and endoplasmic reticulum crosstalk in amyotrophic lateral sclerosis. Neurobiol Dis (2015) 0.76

Emerging Roles of Filopodia and Dendritic Spines in Motoneuron Plasticity during Development and Disease. Neural Plast (2015) 0.76

Genetic ablation of IP3 receptor 2 increases cytokines and decreases survival of SOD1G93A mice. Hum Mol Genet (2016) 0.75

Benzodiazepinone derivatives protect against endoplasmic reticulum stress-mediated cell death in human neuronal cell lines. ACS Chem Neurosci (2015) 0.75

Gamma motor neurons survive and exacerbate alpha motor neuron degeneration in ALS. Proc Natl Acad Sci U S A (2016) 0.75

Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery. J Neuroimmune Pharmacol (2017) 0.75

NSC-34 Motor Neuron-Like Cells Are Unsuitable as Experimental Model for Glutamate-Mediated Excitotoxicity. Front Cell Neurosci (2016) 0.75

Degeneration of spinal motor neurons by chronic AMPA-induced excitotoxicity in vivo and protection by energy substrates. Acta Neuropathol Commun (2015) 0.75

PP2A ligand ITH12246 protects against memory impairment and focal cerebral ischemia in mice. ACS Chem Neurosci (2013) 0.75

Susceptibility-weighted imaging provides insight into white matter damage in amyotrophic lateral sclerosis. PLoS One (2015) 0.75

Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol (2017) 0.75

Generation and validation of novel adeno-associated viral vectors for the analysis of Ca(2+) homeostasis in motor neurons. Sci Rep (2017) 0.75

Changes in the excitability of neocortical neurons in a mouse model of amyotrophic lateral sclerosis are not specific to corticospinal neurons and are modulated by advancing disease. J Neurosci (2017) 0.75

Capturing intracellular Ca(2+) dynamics in computational models of neurodegenerative diseases. Drug Discov Today Dis Models (2017) 0.75

Articles by these authors

Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci (2004) 3.31

Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet (2006) 3.04

Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet (2004) 3.00

Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival. J Cell Biol (2008) 2.91

Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat Genet (2004) 2.86

ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study. Lancet Neurol (2007) 2.80

EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat Med (2012) 2.65

HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nat Med (2011) 2.60

Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis. Brain (2013) 1.78

Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration. Hum Mol Genet (2008) 1.46

Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity. Proc Natl Acad Sci U S A (2007) 1.42

Ca2+, mitochondria and selective motoneuron vulnerability: implications for ALS. Trends Neurosci (2005) 1.41

Cu/Zn superoxide dismutase typical for familial amyotrophic lateral sclerosis increases the vulnerability of mitochondria and perturbs Ca2+ homeostasis in SOD1G93A mice. Mol Pharmacol (2008) 1.30

HDAC6 at the Intersection of Neuroprotection and Neurodegeneration. Traffic (2012) 1.29

Neurotoxicity of pneumolysin, a major pneumococcal virulence factor, involves calcium influx and depends on activation of p38 mitogen-activated protein kinase. Neurobiol Dis (2002) 1.28

Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase. J Neurosci (2008) 1.27

Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease. BMC Neurosci (2009) 1.26

Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration. J Neurosci (2008) 1.23

Small heat-shock protein HSPB1 mutants stabilize microtubules in Charcot-Marie-Tooth neuropathy. J Neurosci (2011) 1.12

Prospective exploration of biochemical tissue composition via imaging mass spectrometry guided by principal component analysis. Pac Symp Biocomput (2007) 1.09

Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish. Hum Mol Genet (2007) 1.08

Upregulation of HSP27 in a transgenic model of ALS. J Neuropathol Exp Neurol (2002) 1.05

GluR2 deficiency accelerates motor neuron degeneration in a mouse model of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol (2005) 1.04

The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis. Neurosci Lett (2003) 1.03

The neurobiology of amyotrophic lateral sclerosis. Eur J Neurosci (2010) 1.02

Loss of T cell microRNA provides systemic protection against autoimmune pathology in mice. J Autoimmun (2012) 1.00

Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death. Neurobiol Dis (2007) 1.00

VEGF protects motor neurons against excitotoxicity by upregulation of GluR2. Neurobiol Aging (2009) 0.99

Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment. Neurobiol Dis (2003) 0.98

Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS. Hum Mol Genet (2013) 0.97

The neurotrophic properties of progranulin depend on the granulin E domain but do not require sortilin binding. Neurobiol Aging (2013) 0.94

Impact of mitochondrial inhibition on excitability and cytosolic Ca2+ levels in brainstem motoneurones from mouse. J Physiol (2003) 0.93

Selective mitochondrial Ca2+ uptake deficit in disease endstage vulnerable motoneurons of the SOD1G93A mouse model of amyotrophic lateral sclerosis. J Physiol (2013) 0.93

Functional analysis of glutamate transporters in excitatory synaptic transmission of GLAST1 and GLAST1/EAAC1 deficient mice. Brain Res Mol Brain Res (2004) 0.91

Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis. J Neurochem (2008) 0.91

Spatial profiles of store-dependent calcium release in motoneurones of the nucleus hypoglossus from newborn mouse. J Physiol (2003) 0.89

Microglial upregulation of progranulin as a marker of motor neuron degeneration. J Neuropathol Exp Neurol (2010) 0.89

Aire mediates thymic expression and tolerance of pancreatic antigens via an unconventional transcriptional mechanism. Eur J Immunol (2012) 0.86

Rapamycin increases survival in ALS mice lacking mature lymphocytes. Mol Neurodegener (2013) 0.86

Mitochondrial Ca2+ buffering in hypoglossal motoneurons from mouse. Neurosci Lett (2005) 0.85

Mutant HSPB8 causes motor neuron-specific neurite degeneration. Hum Mol Genet (2010) 0.85

G37R SOD1 mutant alters mitochondrial complex I activity, Ca(2+) uptake and ATP production. Cell Calcium (2011) 0.84

Low Ca2+ buffering in hypoglossal motoneurons of mutant SOD1 (G93A) mice. Neurosci Lett (2008) 0.84

Serotonergic modulation of intracellular calcium dynamics in neonatal hypoglossal motoneurons from mouse. Brain Res (2004) 0.84

Role of mitochondria in kainate-induced fast Ca2+ transients in cultured spinal motor neurons. Cell Calcium (2007) 0.84

Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) mice. Mol Neurodegener (2014) 0.83

Genetic variant in the HSPB1 promoter region impairs the HSP27 stress response. Hum Mutat (2007) 0.83

Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases. Muscle Nerve (2006) 0.83

Long-lasting changes in GABA responsiveness in cultured neurons. Neurosci Lett (2004) 0.81

Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol Dis (2006) 0.81

Expression of a Cu,Zn superoxide dismutase typical for familial amyotrophic lateral sclerosis increases the vulnerability of neuroblastoma cells to infectious injury. BMC Infect Dis (2007) 0.81

Role of matrix metalloproteinase-9 in a mouse model for amyotrophic lateral sclerosis. Neuroreport (2005) 0.81

Microglia in amyotrophic lateral sclerosis. Acta Neurol Belg (2007) 0.80

Synthesis of benzothiophene-based hydroxamic acids as potent and selective HDAC6 inhibitors. Chem Commun (Camb) (2015) 0.80

Charcot-Marie-Tooth disease: emerging mechanisms and therapies. Int J Biochem Cell Biol (2012) 0.80

The role of oligodendroglial dysfunction in amyotrophic lateral sclerosis. Neurodegener Dis Manag (2014) 0.79

Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice. Neurobiol Dis (2013) 0.78

Fatigability of spinal reflex transmission in a mouse model (SOD1(G93A) ) of amyotrophic lateral sclerosis. Muscle Nerve (2011) 0.78

Neuronal overexpression of IP₃ receptor 2 is detrimental in mutant SOD1 mice. Biochem Biophys Res Commun (2012) 0.78

Progranulin does not affect motor neuron degeneration in mutant SOD1 mice and rats. Neurobiol Aging (2013) 0.77

Polymorphisms in the GluR2 gene are not associated with amyotrophic lateral sclerosis. Neurobiol Aging (2010) 0.76

L-β-N-oxalyl-α,β-diaminopropionic acid toxicity in motor neurons. Neuroreport (2011) 0.75